{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T08:39:40Z","timestamp":1758271180744},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.contraception.2010.01.022","type":"journal-article","created":{"date-parts":[[2010,3,2]],"date-time":"2010-03-02T04:47:41Z","timestamp":1267505261000},"page":"131-138","source":"Crossref","is-referenced-by-count":19,"title":["Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"82","author":[{"given":"Roberto","family":"Uras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Orr\u00f9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Pani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Francesca","family":"Marotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Pilloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Guerriero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Etzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierina","family":"Zedda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Sorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Lello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Benedetto","family":"Melis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2010.01.022_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1749-6632.1993.tb43875.x","article-title":"Results of an open one-year study with Diane-35 in women with polycystic ovarian syndrome","volume":"687","author":"Golland","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.contraception.2010.01.022_bib2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0010-7824(90)90002-D","article-title":"Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome","volume":"42","author":"Falsetti","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.01.022_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmi005","article-title":"Combined oral contraceptives in the treatment of polycystic ovary syndrome","volume":"11","author":"Vrb\u00edkov\u00e1","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2010.01.022_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.maturitas.2008.11.011","article-title":"Pharmacological profile of progestins","volume":"61","author":"Sitruk-Ware","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2010.01.022_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0010-7824(02)00436-5","article-title":"Effect of four different oral contraceptives on various sex hormones and serum-binding globulins","volume":"67","author":"Wiegratz","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.01.022_bib6","series-title":"Pharmakologie der gestagene","first-page":"28","author":"Kuhl","year":"1999"},{"key":"10.1016\/j.contraception.2010.01.022_bib7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.contraception.2008.10.017","article-title":"Profile of the progesterone derivative chlormadinone acetate \u2014 pharmocodynamic properties and therapeutic applications","volume":"79","author":"Druckmann","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.01.022_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000226601","article-title":"Comparative effects of chlormadinone acetate and its 3alpha- and 3beta-hydroxy metabolites on progesterone, androgen and glucocorticoid receptors","volume":"84","author":"Schneider","year":"2009","journal-title":"Pharmacology"},{"key":"10.1016\/j.contraception.2010.01.022_bib9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00003495-200464070-00005","article-title":"Ethinylestradiol\/chlormadinone acetate","volume":"64","author":"Curran","year":"2004","journal-title":"Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2010.01.022_bib10","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2010.01.022_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00003495-200363050-00003","article-title":"Progestogens with antiandrogenic properties","volume":"63","author":"Raudrant","year":"2003","journal-title":"Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2010.01.022_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/13625180500434889","article-title":"Chlormadinone acetate (CMA) in oral contraception \u2014 a new opportunity","volume":"10","author":"Bouchard","year":"2005","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.01.022_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0002-9378(87)90238-9","article-title":"Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone","volume":"156","author":"Jung-Hoffmann","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.01.022_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0010-7824(02)00536-X","article-title":"A 12-month evaluation of the CMA-containing oral contraceptive Belara: efficacy, tolerability and anti-androgenic properties","volume":"67","author":"Schramm","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.01.022_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.contraception.2007.03.014","article-title":"Switching hormonal contraceptives to a chlormadinone acetate-containing oral contraceptive. The Contraceptive Switch Study","volume":"76","author":"Schramm","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.01.022_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.contraception.2009.02.016","article-title":"Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial","volume":"80","author":"Plewig","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.01.022_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.contraception.2008.08.007","article-title":"Evidence that in healthy young women, a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol plus 2 mg of chlormadinone acetate reduces fat mass","volume":"79","author":"Uras","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.01.022_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.contraception.2009.01.012","article-title":"Route of administration of contraceptives containing desogestrel\/etonorgestrel and insulin sensitivity: a prospective randomized study","volume":"80","author":"Cagnacci","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.01.022_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.contraception.2008.08.011","article-title":"The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters","volume":"79","author":"Winkler","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.01.022_bib20","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0015-0282(16)57966-7","article-title":"Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome","volume":"64","author":"Paoletti","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.01.022_bib21","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.01.022_bib22","series-title":"Acne: morphogenesis and treatment","first-page":"162","author":"Plewig","year":"1975"},{"key":"10.1016\/j.contraception.2010.01.022_bib23","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.clnu.2004.09.012","article-title":"Bioelectrical impedance analysis-part II: utilization in clinical practice","volume":"23","author":"Kyle","year":"2004","journal-title":"Clin Nutr"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2010.01.022_bib24","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1007\/s00592-003-0066-2","article-title":"Total body water estimation using bioelectrical impedance: a meta-analysis of the data available in the literature","volume":"40","author":"Martinoli","year":"2003","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.contraception.2010.01.022_bib25","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1152\/jappl.1999.87.3.1087","article-title":"Single- and multifrequency models for bioelectrical impedance analysis of body water compartments","volume":"87","author":"Gudivaka","year":"1999","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.contraception.2010.01.022_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0015-0282(16)58563-X","article-title":"The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome","volume":"66","author":"Paoletti","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.01.022_bib27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0026-0495(83)90004-5","article-title":"Decreased hepatic insulin extraction in subjects with mild glucose intolerance","volume":"32","author":"Bonora","year":"1983","journal-title":"Metabolism"},{"key":"10.1016\/j.contraception.2010.01.022_bib28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2337\/diabetes.33.5.486","article-title":"C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations","volume":"33","author":"Polonsky","year":"1984","journal-title":"Diabetes"},{"key":"10.1016\/j.contraception.2010.01.022_bib29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/meta.2002.31975","article-title":"Evaluation of assays available to measure free testosterone","volume":"51","author":"Morley","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.contraception.2010.01.022_bib30","first-page":"128","volume":"vol. 78","author":"Thomas","year":"1997"},{"key":"10.1016\/j.contraception.2010.01.022_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.gyobfe.2004.12.002","article-title":"The antigonadrotropic activity of chlormadinone acetate in reproductive women","volume":"33","author":"Chassard","year":"2005","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.contraception.2010.01.022_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2131\/jts.26.119","article-title":"The effects of chlormadinone acetate (CMA), antiandrogen, on the pituitary, testis, prostate and adrenal gland of the dog with spontaneous benign prostatic hyperplasia","volume":"26","author":"Murakoshi","year":"2001","journal-title":"J Toxicol Sci"},{"key":"10.1016\/j.contraception.2010.01.022_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0303-7207(02)00377-5","article-title":"Evidence that chlormadinone acetate exhibits antiandrogenic activity in androgen-dependent cell line","volume":"198","author":"T\u00e9rouanne","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.contraception.2010.01.022_bib34","article-title":"Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria","author":"Huang","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.01.022_bib35","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2265.2005.02256.x","article-title":"Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS)","volume":"62","author":"Kumar","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.contraception.2010.01.022_bib36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0015-0282(99)00275-7","article-title":"Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism","volume":"72","author":"Paoletti","year":"1999","journal-title":"Fertil Steril"},{"issue":"6 Pt 1","key":"10.1016\/j.contraception.2010.01.022_bib37","first-page":"E851","article-title":"Effects of short-term testosterone exposure on insulin sensitivity of muscles in female rats","volume":"262","author":"Holm\u00e4ng","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.contraception.2010.01.022_bib38","first-page":"831","article-title":"Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics","volume":"14","author":"Hennes","year":"1990","journal-title":"Int J Obes"},{"key":"10.1016\/j.contraception.2010.01.022_bib39","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1172\/JCI115534","article-title":"Fatty acids in the portal vein of the rat regulate hepatic insulin clearance","volume":"88","author":"Svedberg","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.contraception.2010.01.022_bib40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0015-0282(16)49211-3","article-title":"Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion","volume":"45","author":"Geffner","year":"1986","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.01.022_bib41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1210\/jcem-70-3-699","article-title":"Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome","volume":"70","author":"Dunaif","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.01.022_bib42","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1210\/jc.82.9.3074","article-title":"The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women","volume":"82","author":"Nader","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.01.022_bib43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1210\/jc.74.1.64","article-title":"Insulin resistance, secretion, and metabolism in users of oral contraceptives","volume":"74","author":"Godsland","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.01.022_bib44","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1210\/jc.2003-030328","article-title":"Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel","volume":"88","author":"Cagnacci","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.01.022_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/qjmed\/94.1.31","article-title":"Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol\/cyproterone acetate","volume":"94","author":"Armstrong","year":"2001","journal-title":"QJM"},{"key":"10.1016\/j.contraception.2010.01.022_bib46","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2003-031158","article-title":"Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study","volume":"89","author":"Guido","year":"2004","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410000429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410000429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,26]],"date-time":"2019-05-26T10:42:28Z","timestamp":1558867348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782410000429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0010782410000429"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2010.01.022","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}